Penumbra (PEN) Research & Development (2014 - 2026)
Penumbra (PEN) reported Research & Development of $22.4 million for Q1 2026, up 1.38% year-over-year from $22.1 million in Q1 2025, and up 2.7% on a QoQ basis from $21.8 million in Q4 2025.
Penumbra (PEN) has 13 years of Research & Development data on file, last reported at $22.4 million in Q1 2026.
- Quarterly Research & Development rose 1.38% year-over-year to $22.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90.1 million (down 2.35% YoY) and the FY2025 annual result came in at $89.8 million, down 5.29% from the prior year.
- Research & Development grew to $22.4 million in Q1 2026 per PEN's latest filing, from $21.8 million in the prior quarter.
- Across five years, Research & Development topped out at $25.2 million in Q3 2024 and bottomed at $18.0 million in Q4 2022.
- The 5-year median for Research & Development is $21.8 million (2025), against an average of $21.8 million.
- Peak annual rise in Research & Development reached 27.41% in 2022, while the deepest fall reached 65.46% in 2022.
- Tracing PEN's Research & Development over 5 years: stood at $18.0 million in 2022, then gained by 22.14% to $21.9 million in 2023, then dropped by 8.81% to $20.0 million in 2024, then climbed by 8.92% to $21.8 million in 2025, then advanced by 2.7% to $22.4 million in 2026.
- Per Business Quant, the three latest PEN Research & Development figures stand at $22.4 million (Q1 2026), $21.8 million (Q4 2025), and $22.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 22.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.38 Mn |
| Dec 31, 2025 | 21.79 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 23.22 Mn |
| Mar 31, 2025 | 22.08 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Sep 30, 2024 | 25.21 Mn |
| Jun 30, 2024 | 24.94 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 21.94 Mn |
| Sep 30, 2023 | 20.96 Mn |
| Jun 30, 2023 | 21.54 Mn |
| Mar 31, 2023 | 19.99 Mn |
| Dec 31, 2022 | 17.96 Mn |
| Sep 30, 2022 | 21.32 Mn |
| Jun 30, 2022 | 19.56 Mn |
| Mar 31, 2022 | 20.56 Mn |
| Dec 31, 2021 | 52.00 Mn |
| Sep 30, 2021 | 16.73 Mn |
| Jun 30, 2021 | 17.74 Mn |
| Mar 31, 2021 | 18.08 Mn |
| Dec 31, 2020 | 19.46 Mn |
| Sep 30, 2020 | 34.92 Mn |
| Jun 30, 2020 | 22.73 Mn |
| Mar 31, 2020 | 12.95 Mn |
| Dec 31, 2019 | 12.86 Mn |
| Sep 30, 2019 | 13.73 Mn |
| Jun 30, 2019 | 13.46 Mn |
| Mar 31, 2019 | 11.67 Mn |
| Dec 31, 2018 | 10.87 Mn |
| Sep 30, 2018 | 9.09 Mn |
| Jun 30, 2018 | 8.19 Mn |
| Mar 31, 2018 | 8.01 Mn |
| Dec 31, 2017 | 8.40 Mn |
| Sep 30, 2017 | 8.13 Mn |
| Jun 30, 2017 | 8.09 Mn |
| Mar 31, 2017 | 7.03 Mn |
| Dec 31, 2016 | 6.11 Mn |
| Sep 30, 2016 | 6.50 Mn |
| Jun 30, 2016 | 6.26 Mn |
| Mar 31, 2016 | 5.00 Mn |
| Dec 31, 2015 | 5.48 Mn |
| Sep 30, 2015 | 4.56 Mn |
| Jun 30, 2015 | 4.79 Mn |
| Mar 31, 2015 | 3.19 Mn |
| Dec 31, 2014 | 4.14 Mn |
| Sep 30, 2014 | 3.90 Mn |